You are here:
| Reference : Okadaic acid, a protein phosphatase inhibitor, enhances transcription of a receptor gene... |
| Scientific journals : Article | |||
| Life sciences : Biochemistry, biophysics & molecular biology | |||
| http://hdl.handle.net/2268/19883 | |||
| Okadaic acid, a protein phosphatase inhibitor, enhances transcription of a receptor gene containing sequence A of the human prolactin promoter | |
| English | |
| Wera, S. [> > > >] | |
| Belayew, A. [> > > >] | |
Martial, Joseph  [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >] | |
| 1993 | |
| Molecular Endocrinology | |
| Endocrine Society | |
| 7 | |
| 8 | |
| 965-71 | |
| 0888-8809 | |
| Chevy Chase | |
| MD | |
| [en] Calcium/pharmacology/physiology ; Calcium Channels/physiology ; Cyclic AMP/pharmacology/physiology ; Drug Synergism ; Ethers, Cyclic/*pharmacology ; Humans ; Okadaic Acid ; Prolactin/*genetics ; *Promoter Regions, Genetic ; Recombinant Fusion Proteins/*biosynthesis/genetics ; Transcription, Genetic/*genetics | |
| [en] Human PRL (hPRL) gene expression is controlled by cAMP and Ca2+. This control is mediated by two cis-elements: a Pit-1 binding site (-62 to -35) and sequence A (-110 to -85), present in the hPRL promoter. We have investigated whether protein phosphatases could be involved in this regulation. GC-type rat pituitary tumor cells were transfected with sequence -138 to -35 of the hPRL gene promoter, upstream from a thymidine kinase promoter and a chloramphenicol acetyltransferase (CAT) reporter gene. Addition of okadaic acid (OA), a specific inhibitor of protein phosphatases 1 and 2A, stimulates transient expression of the CAT gene. The dose-response curve shows a maximal effect at 25 nM OA (2.2-fold stimulation above controls). The OA effect is also observed with a natural 4500-base pair hPRL promoter. A single copy of the hPRL promoter sequence -115 to -85 (sequence A) confers to a thymidine kinase-CAT construct an identical response to OA, whereas a single copy of the proximal Pit-1 binding site does not. Synergism is observed between cAMP and OA in activating PRL gene transcription. This synergism is also observed with a single copy of sequence A. The effect of cAMP is not mediated by an L-type Ca2+ channel, since addition of the Ca2+ channel antagonist verapamil does not decrease it, nor does complexing extracellular Ca2+ significantly reduce it. Furthermore, OA and the Ca2+ channel opener BAY K8644 exert additive effects. | |
| http://hdl.handle.net/2268/19883 | |
| http://mend.endojournals.org/cgi/content/abstract/7/8/965 | |
| 1993/08/01 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
